These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 25206914)
1. Zhichan decoction induces differentiation of dopaminergic neurons in Parkinson's disease rats after neural stem cell transplantation. Shi H; Song J; Yang X Neural Regen Res; 2014 May; 9(9):931-6. PubMed ID: 25206914 [TBL] [Abstract][Full Text] [Related]
2. Zhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease rats. Zhou Q; Chen J; Yi S; Lou Y; Tang W; Liu Y; Zhang P Neural Regen Res; 2012 Sep; 7(27):2107-14. PubMed ID: 25558223 [TBL] [Abstract][Full Text] [Related]
3. X-box-binding protein 1-modified neural stem cells for treatment of Parkinson's disease. Si L; Xu T; Wang F; Liu Q; Cui M Neural Regen Res; 2012 Apr; 7(10):736-40. PubMed ID: 25737695 [TBL] [Abstract][Full Text] [Related]
4. Effects of Zhichan powder on signal transduction and apoptosis-associated gene expression in the substantia nigra of Parkinson's disease rats. Chen J; Ma J; Qiu Y; Yi S; Liu Y; Zhou Q; Zhang P; Wan Q; Kuang Y Neural Regen Res; 2012 Sep; 7(27):2115-22. PubMed ID: 25558224 [TBL] [Abstract][Full Text] [Related]
5. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872 [TBL] [Abstract][Full Text] [Related]
6. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo. Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984 [TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology Analysis on Zhichan Powder in the Treatment of Parkinson's Disease. Li J; Qi X; Sun Y; Zhang Y; Chen J Comb Chem High Throughput Screen; 2020; 23(1):28-40. PubMed ID: 31899674 [TBL] [Abstract][Full Text] [Related]
8. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Wang X; Lu Y; Zhang H; Wang K; He Q; Wang Y; Liu X; Li L; Wang X Int J Dev Neurosci; 2004 Jun; 22(4):175-83. PubMed ID: 15245752 [TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats. Krasnova IN; Bychkov ER; Lioudyno VI; Zubareva OE; Dambinova SA Neuroscience; 2000; 95(1):113-7. PubMed ID: 10619467 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived mesenchymal stem cells increase dopamine synthesis in the injured striatum. Huang Y; Chang C; Zhang J; Gao X Neural Regen Res; 2012 Dec; 7(34):2653-62. PubMed ID: 25337111 [TBL] [Abstract][Full Text] [Related]
11. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease. Ossowska K; Smiałowska M; Kuter K; Wierońska J; Zieba B; Wardas J; Nowak P; Dabrowska J; Bortel A; Biedka I; Schulze G; Rommelspacher H Neuroscience; 2006 Sep; 141(4):2155-65. PubMed ID: 16797138 [TBL] [Abstract][Full Text] [Related]
12. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154 [TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Srinivasan J; Schmidt WJ Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435 [TBL] [Abstract][Full Text] [Related]
14. Effects of Combined Bushen Zhichan Recipe and Levodopa in a Rodent Model of Parkinson Disease: Potential Mechanisms. Li W; Gao H; Li W Med Sci Monit; 2020 Jun; 26():e922345. PubMed ID: 32555131 [TBL] [Abstract][Full Text] [Related]
15. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease. Cheng B; Yang X; An L; Gao B; Liu X; Liu S Brain Res; 2009 Aug; 1286():25-31. PubMed ID: 19559687 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Srinivasan J; Schmidt WJ Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465 [TBL] [Abstract][Full Text] [Related]
17. Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats. Chaturvedi RK; Shukla S; Seth K; Agrawal AK Exp Neurol; 2008 Apr; 210(2):608-23. PubMed ID: 18272152 [TBL] [Abstract][Full Text] [Related]
18. Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells. Takahashi H; Ishikawa H; Tanaka A Hum Cell; 2017 Apr; 30(2):60-71. PubMed ID: 28210976 [TBL] [Abstract][Full Text] [Related]
19. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767 [TBL] [Abstract][Full Text] [Related]
20. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model. Gu S; Huang H; Bi J; Yao Y; Wen T Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]